Full-Time

Manager – Medicaid Market Research and Competitive Analysis

Updated on 8/17/2026

Deadline 8/29/26
CVS Health

CVS Health

10,001+ employees

Healthcare, insurance, PBM, and retail pharmacy

Compensation Overview

$60.3k - $132.6k/yr

+ Bonus + Commission + Short-term incentive

Company Historically Provides H1B Sponsorship

New Mexico, USA + 31 more

More locations: Kansas, USA | Pennsylvania, USA | Delaware, USA | Iowa, USA | Vermont, USA | Wyoming, USA | Connecticut, USA | Texas, USA | Florida, USA | South Dakota, USA | Georgia, USA | Arizona, USA | Tennessee, USA | Virginia, USA | Arkansas, USA | Minnesota, USA | Nebraska, USA | Utah, USA | Kentucky, USA | New York, NY, USA | Maryland, USA | Maine, USA | North Carolina, USA | Oklahoma, USA | Ohio, USA | New Jersey, USA | Louisiana, USA | Michigan, USA | Illinois, USA | Alabama, USA | Idaho, USA

Remote

Remote within the listed U.S. states; travel up to 25% is required.

Bachelor's

Category
Business & Strategy (1)
Required Skills
SharePoint
Market Research
Word/Pages/Docs
Data Analysis
Excel/Numbers/Sheets

Get referred to CVS Health

See people who can refer or advise you

Requirements
  • At least 5 years of experience in Medicaid managed care.
  • At least 5 years of specialized experience in market research, competitive intelligence, or strategic analysis.
  • Experience developing competitor analyses and actionable insights.
  • Experience creating Microsoft PowerPoint presentations that transform detailed research into clear, well-organized slides supporting executive decision-making.
  • Strong organizational and analytical skills, including experience managing multiple projects and shifting priorities under tight deadlines.
  • Proven project management skills and a track record of meeting milestones in fast-paced environments.
  • Excellent verbal and written communication skills, including experience translating research into strategic recommendations.
  • Experience communicating effectively with technical and non-technical stakeholders at all organizational levels.
  • Proficiency in Microsoft Word, Excel, and SharePoint.
  • Advanced proficiency with Microsoft PowerPoint.
  • Willingness and ability to travel up to 25% to support capture planning, stakeholder engagement, and strategic proposal activities.
  • A bachelor's degree or equivalent work experience.
Responsibilities
  • Direct in-depth market, customer, and competitor research to inform capture strategy and proposal development.
  • Curate market intelligence on customer and competitor programs, weaknesses, innovations, and performance in new and existing markets.
  • Develop actionable insights from market research to inform strategic decision-making, drive customer-centric approaches, and contribute to organizational growth.
  • Collaborate with the Capture Director, consultants, and business partners to develop research reports, customer and competitor analyses, capture workshop deliverables, and other materials for assigned opportunities.
  • Design and execute research studies, review and assess market data, and translate findings into actionable, data-driven market strategies.
  • Interpret and adapt strategic concepts to instruct or coach business partners and consultants while strategically directing market research and analysis.
  • Organize and maintain research outputs in SharePoint so key insights and source materials are accessible to proposal writers and stakeholders.
  • Structure documentation in a clear, concise, and usable format for quick reference during the RFP response phase.
  • Synthesize research findings into reports, presentations, and dashboards for stakeholders ranging from junior employees to senior executives.
  • Track progress and ensure timely completion of deliverables.
  • Monitor project-team objectives that affect business growth and development goals in existing and new markets.
  • Work independently from strategic direction with limited supervision to complete assignments.
  • Direct proposal team members during the proposal process by providing insight, recommendations, and relevant intelligence for content development.
Desired Qualifications
  • Previous profit-and-loss and/or business development experience and project management experience in a Medicaid managed care setting.
  • Experience leading capture and proposal activities for significant opportunities valued at $1 billion or more.
  • Experience in a capture or executive leadership function for a managed-care product serving state Medicaid agencies.
  • Association of Proposal Management Professionals certifications.
  • State Medicaid agency or federal agency experience with the Centers for Medicare & Medicaid Services.
  • Experience using a variety of electronic collaboration tools.
  • Experience developing competitive analyses.
  • Experience developing executive presentation decks.
  • Managed care operations experience.

CVS Health operates as a diversified health services company in the United States, organized into Health Care Benefits, Pharmacy & Consumer Wellness, and Health Services. Its offerings include medical insurance products, retail and mail-order prescription drugs, and pharmacy benefit management (PBM) services, all connected through its integrated platform. By combining insurance, retail pharmacy, PBM, and health solutions, CVS Health coordinates care and controls costs across touchpoints for individuals, employers, and government programs. The company aims to lower health care costs while improving access and health outcomes for customers.

Company Size

10,001+

Company Stage

IPO

Headquarters

Woonsocket, Rhode Island

Founded

1963

Get referred to CVS Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • CVS raised 2026 adjusted EPS guidance to $7.90-$8.10 on August 5, 2026.
  • CVS and Eli Lilly launch Zepbound and Foundayo pricing in-app by early Q4 2026.
  • CVS opened pharmacy-focused Houston stores and plans nearly 20 nationwide openings.

What critics are saying

  • Reuters said Caremark expects weaker client retention after August 5, 2026 results.
  • Louisiana settled three PBM lawsuits with CVS for $45 million on February 20, 2026.
  • Tennessee's FAIR Rx Act threatens 137 CVS pharmacies and MinuteClinics, risking forced divestiture.

What makes CVS Health unique

  • CVS integrates Aetna, Caremark, and 9,000 pharmacies across U.S. scale.
  • August 5, 2026 results showed all three segments beat revenue expectations.
  • Teresa Heitsenrether joins the board November 18, 2026, signaling data-driven healthcare execution.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Company Equity

Wellness Program

Professional Development Budget

Paid Vacation

Paid Holidays

Company News

Yahoo Finance
Aug 19th, 2026
CVS Health appoints JPMorgan data executive to board as focus shifts to digital healthcare

CVS Health has appointed Teresa Heitsenrether, a senior executive from JPMorgan Chase with extensive data and analytics experience, to its board of directors. The move follows the resignation of board member Larry M. Robbins. The appointment signals CVS Health's focus on technology and data-driven healthcare at the governance level. The company, valued at approximately $120bn, operates an integrated healthcare model spanning insurance, pharmacy benefits, and retail services. Heitsenrether's data expertise aligns with CVS Health's strategy to leverage digital capabilities and operational efficiency across its businesses, including Aetna and Caremark. The company faces challenges including high debt levels and reimbursement pressures in a competitive market alongside UnitedHealth Group and Cigna.

Yahoo Finance
Aug 14th, 2026
CVS Health beats Q2 revenue and profit estimates but faces questions on sustainability

CVS Health reported second quarter revenue of $106.1 billion, beating analyst estimates of $99.41 billion by 6.7%. Adjusted earnings per share came in at $2.58, surpassing expectations of $1.85 by 39.4%. Management attributed strong performance to specialty pharmacy and Medicare Advantage, with CEO David Joyner noting improvements from actions taken in Aetna and Caremark. The company raised its full-year adjusted EPS guidance to $8 at the midpoint. However, analysts raised concerns about sustainability. Management acknowledged ongoing challenges in the 340B program and normalisation of script share gains from Rite Aid. To offset these headwinds, executives pointed to biosimilars and investments in service technology. The company has committed $20 billion over a decade to AI and technology investments, with operational savings already being realised.

Fox Business
Aug 13th, 2026
Nine major PBMs to display TrumpRx prescription drug prices from 2027

Nine pharmacy benefit managers will integrate TrumpRx prescription drug pricing into their benefit tools, effective 1 January 2027. The Pharmaceutical Care Management Association and participating PBMs—including CVS Health, Express Scripts, Humana, and OptumRx—will display cash prices from TrumpRx alongside plan coverage costs. The agreement covers commercial, Medicare, and Medicaid plans. Patients will see TrumpRx prices for all listed drugs, whether through presidential deals or standard pricing. CMS Administrator Dr Mehmet Oz said the commitment will help patients compare prices and find better deals. PCMA CEO David Marin stated the transparency will allow consumers to make better-informed choices about prescription drug costs. Some PBMs will use Real Time Benefit Tools to display pricing comparisons, whilst others may employ different methods.

Yahoo Finance
Aug 11th, 2026
AbbVie acquires Apogee Therapeutics for $10.9B amid pipeline expansion

AbbVie has announced a $10.9 billion acquisition of Apogee Therapeutics in June 2026, aiming to strengthen its drug pipeline. The biopharmaceutical company reported FY 2025 revenue of nearly $61.2 billion, up roughly 8.6% year-on-year. Net income reached close to $4.2 billion, reflecting a net margin of approximately 6.9%, down from 7.6% the previous year. Free cash flow for the period was nearly $17.8 billion. CVS Health reported FY 2025 revenue of approximately $402.1 billion, representing growth of nearly 7.8%. The integrated healthcare provider serves around 37 million medical members and manages 1.9 billion prescriptions annually through its Health Services segment. Net income was close to $1.8 billion, yielding a net margin of roughly 0.4%, down from 1.2% in FY 2024.

Yahoo Finance
Aug 5th, 2026
CVS Health Q2 earnings beat expectations, partners with Eli Lilly on weight loss drugs

CVS Health reported second-quarter net income of $2.98 billion, or $2.31 per share, significantly beating analyst expectations of $1.85 per share. Revenue rose 7% to $106.10 billion, surpassing the forecast of $100.11 billion. The company raised its full-year adjusted earnings guidance to between $7.90 and $8.10 per share, up from $7.30 to $7.50 per share. Revenue guidance increased to at least $414 billion from $405 billion. CVS announced a partnership with Eli Lilly, with the CVS Health app to display pricing for Lilly's weight loss drugs Zepbound and Foundayo starting in early fourth quarter 2026. The company also reduced MinuteClinic virtual weight loss consultations to $29, eliminating membership fees.